Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinoma

BACKGROUND: New treatment strategies are needed to improve outcomes for patients with advanced cholangiocarcinoma (CCA) due to the limited efficacy of current first-line chemotherapy regimens. Although the combination of hepatic arterial infusion chemotherapy (HAIC), lenvatinib, and programmed cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zhanqi, Wang, Yajing, Wu, Boyang, Liu, Ying, Wang, Yaqin, Ren, Zhizhong, Yang, Xiaowei, Chen, Qian, Zhang, Yuewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502306/
https://www.ncbi.nlm.nih.gov/pubmed/37720223
http://dx.doi.org/10.3389/fimmu.2023.1235724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502306/
https://www.ncbi.nlm.nih.gov/pubmed/37720223
http://dx.doi.org/10.3389/fimmu.2023.1235724

Ejemplares similares